SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-014003
Filing Date
2021-11-02
Accepted
2021-11-02 08:30:43
Documents
59
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q glyc-20210930x10q.htm   iXBRL 10-Q 1308658
2 EX-10.1 glyc-20210930xex10d1.htm EX-10.1 155324
3 EX-31.1 glyc-20210930xex31d1.htm EX-31.1 16959
4 EX-31.2 glyc-20210930xex31d2.htm EX-31.2 16775
5 EX-32.1 glyc-20210930xex32d1.htm EX-32.1 9438
  Complete submission text file 0001558370-21-014003.txt   5529503

Data Files

Seq Description Document Type Size
6 EX-101.SCH glyc-20210930.xsd EX-101.SCH 34602
7 EX-101.CAL glyc-20210930_cal.xml EX-101.CAL 37320
8 EX-101.DEF glyc-20210930_def.xml EX-101.DEF 169416
9 EX-101.LAB glyc-20210930_lab.xml EX-101.LAB 304829
10 EX-101.PRE glyc-20210930_pre.xml EX-101.PRE 287135
11 EXTRACTED XBRL INSTANCE DOCUMENT glyc-20210930x10q_htm.xml XML 900276
Mailing Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-243-1201
GLYCOMIMETICS INC (Filer) CIK: 0001253689 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36177 | Film No.: 211369390
SIC: 2834 Pharmaceutical Preparations